The relative importance of patient-reported barriers to colorectal cancer screening
- PMID: 20347555
- PMCID: PMC2946819
- DOI: 10.1016/j.amepre.2010.01.020
The relative importance of patient-reported barriers to colorectal cancer screening
Abstract
Background: Colorectal cancer (CRC) screening rates are suboptimal. The most important barriers identified by patients are poorly understood. A comprehensive assessment of barriers to all recommended modalities is needed.
Methods: In 2007, a questionnaire was mailed to 6100 patients, aged 50-75 years, from 12 family medicine practices in the Virginia Ambulatory Care Outcomes Research Network. People aged 65-75 years and African Americans were oversampled. Patients were asked to rate 19-21 barriers to each of four recommended tests. In 2008, responses were coded on a 5-point scale; higher scores reflected stronger barrier endorsement.
Results: The response rate was 55% (n=3357). Approximately 40% of respondents were aged >/=65 years, 30% were African-American, and 73% were adherent to screening. A clinician's failure to suggest screening and not knowing testing was necessary received the highest mean scores as barriers. Financial concerns and misconceptions were also cited. Barrier scores differed depending on whether respondents were never screened, overdue for screening, or adherent to guidelines. The top five barriers for each modality included test-specific barriers (e.g., handling stool, bowel preparation), which often outranked generic barriers to screening. Not knowing testing was necessary was a top barrier for all tests but colonoscopy.
Conclusions: Although physician advice and awareness of the need for screening are important, barriers to screening are not homogenous across tests, and test-specific barriers warrant consideration in designing strategies to improve screening rates. Barrier scores differ by screening status, highlighting the need to address prior screening experience. Evidence that patients are more familiar with colonoscopy than with other modalities suggests an opportunity to improve screening rates by educating patients about alternative tests.
2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis.Am J Prev Med. 2010 May;38(5):508-16. doi: 10.1016/j.amepre.2010.01.021. Am J Prev Med. 2010. PMID: 20409499 Free PMC article.
-
Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995. JAMA Netw Open. 2019. PMID: 31860105 Free PMC article.
-
Attitudes toward colorectal cancer screening in the digital age: a survey of practices and attitudes among screening-eligible Alabamians.South Med J. 2013 Aug;106(8):462-7. doi: 10.1097/SMJ.0b013e3182a0e7be. South Med J. 2013. PMID: 23912141
-
Patient-Reported Needs Following a Referral for Colorectal Cancer Screening.Am J Prev Med. 2019 Feb;56(2):271-280. doi: 10.1016/j.amepre.2018.08.017. Epub 2018 Dec 13. Am J Prev Med. 2019. PMID: 30554975 Free PMC article.
-
Patients' experiences and reported barriers to colonoscopy in the screening context--a systematic review of the literature.Patient Educ Couns. 2012 Feb;86(2):137-46. doi: 10.1016/j.pec.2011.04.010. Epub 2011 Jun 2. Patient Educ Couns. 2012. PMID: 21640543 Review.
Cited by
-
Optimising Surveillance in Hepatocellular Carcinoma: Patient-Defined Obstacles and Solutions.J Hepatocell Carcinoma. 2024 Aug 23;11:1597-1605. doi: 10.2147/JHC.S462303. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 39193064 Free PMC article.
-
Colorectal Cancer Polygenic Risk Score Is Associated With Screening Colonoscopy Findings but Not Follow-Up Outcomes.Gastro Hep Adv. 2023 Oct 10;3(2):151-161. doi: 10.1016/j.gastha.2023.10.001. eCollection 2024. Gastro Hep Adv. 2023. PMID: 39129957 Free PMC article.
-
Patient-Provider Communication and Colorectal Cancer Screening Completion Using Multi-target Stool DNA Testing.J Cancer Educ. 2024 Jul 20. doi: 10.1007/s13187-024-02479-w. Online ahead of print. J Cancer Educ. 2024. PMID: 39031303
-
Implementation of Health IT for Cancer Screening in US Primary Care: Scoping Review.JMIR Cancer. 2024 Apr 30;10:e49002. doi: 10.2196/49002. JMIR Cancer. 2024. PMID: 38687595 Free PMC article. Review.
-
Colorectal cancer literacy and related factors in northeast of Iran: A cross-sectional study.Cancer Rep (Hoboken). 2024 Mar;7(3):e2037. doi: 10.1002/cnr2.2037. Cancer Rep (Hoboken). 2024. PMID: 38522011 Free PMC article.
References
-
- American Cancer Society. Cancer facts and figures, 2009. Atlanta, GA: American Cancer Society; 2009.
-
- Winawer S, Fletcher R, Rex D, et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003;124:544–60. - PubMed
-
- Smith RA, Cokkinides V, Brawley OW. Cancer screening in the U.S., 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009 Jan–Feb;59(1):27–41. Review. - PubMed
-
- U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. U.S. Preventive Services Task Force. Ann Intern Med. 2008 Nov 4;149(9):627–37. Epub 2008 Oct 6. - PubMed
- Summary for patients. Ann Intern Med. 2008 Nov 4;149(9):I–44. - PubMed
-
- CDC. Use of colorectal cancer tests—U.S., 2002, 2004, 2006. MMWR. 2008;57(10):253–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
